That's because if you do enough data analyses on a drug, even one that doesn't work at all, you can eventually find a group in which the drug appears to be effective--entirely by chance.
Risk measurement entails complex correlation analyses and what-if scenarios, and there is a trend among financial services firms to outsource this work, says Morningstar analyst Swami Shanmugasundaram.